These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 18039782)
1. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Deboer MD; Zhu X; Levasseur PR; Inui A; Hu Z; Han G; Mitch WE; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL Endocrinology; 2008 Feb; 149(2):827-35. PubMed ID: 18039782 [TBL] [Abstract][Full Text] [Related]
2. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. DeBoer MD; Zhu XX; Levasseur P; Meguid MM; Suzuki S; Inui A; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL Endocrinology; 2007 Jun; 148(6):3004-12. PubMed ID: 17347304 [TBL] [Abstract][Full Text] [Related]
3. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats. Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616 [TBL] [Abstract][Full Text] [Related]
4. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors. Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119 [TBL] [Abstract][Full Text] [Related]
5. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice. Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464 [TBL] [Abstract][Full Text] [Related]
6. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model. Northrup R; Kuroda K; Duus EM; Barnes SR; Cheatham L; Wiley T; Pietra C Support Care Cancer; 2013 Sep; 21(9):2409-15. PubMed ID: 23579947 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Strassburg S; Anker SD; Castaneda TR; Burget L; Perez-Tilve D; Pfluger PT; Nogueiras R; Halem H; Dong JZ; Culler MD; Datta R; Tschöp MH Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E78-84. PubMed ID: 18460598 [TBL] [Abstract][Full Text] [Related]
8. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276 [TBL] [Abstract][Full Text] [Related]
9. Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice. Tamaki M; Hagiwara A; Miyashita K; Wakino S; Inoue H; Fujii K; Fujii C; Sato M; Mitsuishi M; Muraki A; Hayashi K; Doi T; Itoh H Endocrinology; 2015 Oct; 156(10):3638-48. PubMed ID: 26241123 [TBL] [Abstract][Full Text] [Related]
10. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Bresciani E; Rizzi L; Molteni L; Ravelli M; Liantonio A; Ben Haj Salah K; Fehrentz JA; Martinez J; Omeljaniuk RJ; Biagini G; Locatelli V; Torsello A Endocrine; 2017 Oct; 58(1):106-114. PubMed ID: 27896546 [TBL] [Abstract][Full Text] [Related]
11. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment. Ali S; Chen JA; Garcia JM Curr Opin Support Palliat Care; 2013 Dec; 7(4):368-75. PubMed ID: 24145681 [TBL] [Abstract][Full Text] [Related]
12. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice. Yoshimura M; Shiomi Y; Ohira Y; Takei M; Tanaka T Eur J Pharmacol; 2017 Sep; 811():30-37. PubMed ID: 28529141 [TBL] [Abstract][Full Text] [Related]
14. Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model. Palus S; Schur R; Akashi YJ; Bockmeyer B; Datta R; Halem H; Dong J; Culler MD; Adams V; Anker SD; Springer J PLoS One; 2011; 6(11):e26865. PubMed ID: 22102869 [TBL] [Abstract][Full Text] [Related]
15. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease. Gortan Cappellari G; Semolic A; Ruozi G; Vinci P; Guarnieri G; Bortolotti F; Barbetta D; Zanetti M; Giacca M; Barazzoni R FASEB J; 2017 Dec; 31(12):5159-5171. PubMed ID: 28778977 [TBL] [Abstract][Full Text] [Related]
18. Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness. Hill NE; Murphy KG; Saeed S; Phadke R; Chambers D; Wilson DR; Brett SJ; Singer M PLoS One; 2017; 12(8):e0182659. PubMed ID: 28796827 [TBL] [Abstract][Full Text] [Related]
19. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Barazzoni R; Zhu X; Deboer M; Datta R; Culler MD; Zanetti M; Guarnieri G; Marks DL Kidney Int; 2010 Jan; 77(1):23-8. PubMed ID: 19890275 [TBL] [Abstract][Full Text] [Related]
20. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist. Salomé N; Hansson C; Taube M; Gustafsson-Ericson L; Egecioglu E; Karlsson-Lindahl L; Fehrentz JA; Martinez J; Perrissoud D; Dickson SL J Neuroendocrinol; 2009 Sep; 21(9):777-85. PubMed ID: 19703102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]